Evaluating the effects of pharmaceutical interventions, social policies, and exogeneous shocks on people's health and behavior ABSTRACT Aging individuals tend to suffer from chronic conditions, some of which manifest in midlife (e.g., type 2 diabetes and hypertension) and some in late life (e.g., neurodegenerative disorders). As the global population increases and as people live longer, finding strategies to prevent or delay these diseases has become a key priority. Concurrent advances in public health and biomedicine offer an array of pharmaceutical…